LMAT - LEMAITRE VASCULAR INC

QQQ $ 431.01 $ 6.55 (1.54 %)

DIA $ 382.27 $ 1.39 (0.36 %)

SPY $ 508.26 $ 4.77 (0.95 %)

TLT $ 88.26 $ 0.46 (0.52 %)

GLD $ 216.60 $ 0.70 (0.32 %)

Previous Close

$ 65.46

Open

$ 64.80

Bid

$ 0.00 x 0

Ask

$ 65.30 x 100

Day's Range

$ 64.80 - $ 66.95

52 Week Range

$ 44.04 - $ 74.46

Volume

117,291

Average Volume

Market Cap

1.47B

Beta (5Y Monthly)

$ 0.78

PE Ratio (TTM)

$ 48.76

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.01)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	02-29-2024	12-31-2023	10-K
2	11-07-2023	09-30-2023	10-Q
3	08-08-2023	06-30-2023	10-Q
4	05-09-2023	03-31-2023	10-Q
5	03-01-2023	12-31-2022	10-K
6	11-08-2022	09-30-2022	10-Q
7	08-05-2022	06-30-2022	10-Q
8	05-10-2022	03-31-2022	10-Q
9	02-28-2022	12-31-2021	10-K
10	11-04-2021	09-30-2021	10-Q
11	08-05-2021	06-30-2021	10-Q
12	05-10-2021	03-31-2021	10-Q
13	03-12-2021	12-31-2020	10-K
14	11-06-2020	09-30-2020	10-Q
15	08-06-2020	06-30-2020	10-Q
16	05-08-2020	03-31-2020	10-Q
17	03-12-2020	12-31-2019	10-K
18	11-08-2019	09-30-2019	10-Q
19	08-06-2019	06-30-2019	10-Q
20	05-06-2019	03-31-2019	10-Q
21	03-11-2019	12-31-2018	10-K
22	11-02-2018	09-30-2018	10-Q
23	08-06-2018	06-30-2018	10-Q
24	05-04-2018	03-31-2018	10-Q
25	03-09-2018	12-31-2017	10-K
26	11-03-2017	09-30-2017	10-Q
27	08-03-2017	06-30-2017	10-Q
28	05-04-2017	03-31-2017	10-Q
29	03-09-2017	12-31-2016	10-K
30	11-04-2016	09-30-2016	10-Q
31	08-05-2016	06-30-2016	10-Q
32	05-06-2016	03-31-2016	10-Q
33	03-10-2016	12-31-2015	10-K
34	11-06-2015	09-30-2015	10-Q
35	08-06-2015	06-30-2015	10-Q
36	05-07-2015	03-31-2015	10-Q
37	03-18-2015	12-31-2014	10-K
38	11-06-2014	09-30-2014	10-Q
39	08-07-2014	06-30-2014	10-Q
40	05-08-2014	03-31-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Stifel Upgrades LeMaitre Vascular to Buy, ...
04/26/2024 10:06:10

Stifel analyst Rick Wise upgrades LeMaitre Vascular (NASDAQ:LMAT) from Hold to Buy and raises the price target from $59 to $75.

Barrington Research Maintains Outperform R...
02/28/2024 17:00:36

Barrington Research Maintains Outperform o...
02/28/2024 16:36:26

Barrington Research analyst Michael Petusky maintains LeMaitre Vascular (NASDAQ:LMAT) with a Outperform and raises the price...

LeMaitre Vascular Sees Q1 EPS $0.36-$0.41 ...
02/27/2024 22:39:05

Recap: LeMaitre Vascular Q4 Earnings
02/27/2024 21:45:17

LeMaitre Vascular Q4 2023 GAAP EPS $0.38 B...
02/27/2024 21:42:43

LeMaitre Vascular (NASDAQ:LMAT) reported quarterly earnings of $0.38 per share which beat the analyst consensus estimate of $0....

Earnings Scheduled For February 27, 2024
02/27/2024 10:01:31

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on rev...

A Preview Of LeMaitre Vascular's Earnings
02/26/2024 20:01:49

Keybanc Initiates Coverage On LeMaitre Vas...
02/06/2024 12:08:20

Keybanc analyst Brett Fishbin initiates coverage on LeMaitre Vascular (NASDAQ:LMAT) with a Sector Weight rating.

LeMaitre Vascular Sees Q4 EPS $0.34-$0.38 ...
11/01/2023 21:43:04

Business OutlookQ4 2023 GuidanceFull Year 2023 Guidance Sales$48.0mm - $50.0mm(Mid: $49.0mm, +20%, +16% Org.)$192.6mm - $194.6m...

LeMaitre Vascular Q3 EPS $0.33 Beats $0.30...
11/01/2023 21:40:19

LeMaitre Vascular (NASDAQ:LMAT) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $0....

Earnings Scheduled For November 1, 2023
11/01/2023 11:19:35

Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of...

5 Analysts Have This to Say About LeMaitre...
10/23/2023 17:01:09

JMP Securities Initiates Coverage On LeMai...
10/23/2023 10:02:25

JMP Securities analyst Daniel Stauder initiates coverage on LeMaitre Vascular (NASDAQ:LMAT) with a Market Outperform rating ...

why-lemaitre-vascular-is-a-market-leader-in-core-segments-oppenheimer-initiates-with-outperform-rating

Why LeMaitre Vascular Is A Market Leader I...
09/06/2023 19:04:28

Oppenheimer has initiated coverage on LeMaitre Vascular Inc (NASDAQ: LMAT) with an Outperform rating and a

Benzinga's Top Ratings Upgrades, Downgrade...
09/06/2023 15:00:37

Oppenheimer Initiates Coverage On LeMaitre...
09/06/2023 08:44:51

Oppenheimer analyst Suraj Kalia initiates coverage on LeMaitre Vascular (NASDAQ:LMAT) with a Outperform rating and announces...

Benzinga's Top Ratings Upgrades, Downgrade...
08/03/2023 15:00:48

Yum! Brands To Rally Around 20%? Here Are ...
08/03/2023 12:06:26

Needham raised the price target for Extreme Networks, Inc. (NASDAQ: EXTR) from $30 to $35. Needham analyst Alex Henderson m...

Jefferies Downgrades LeMaitre Vascular to ...
08/03/2023 09:49:08

Jefferies analyst Anthony Petrone downgrades LeMaitre Vascular (NASDAQ:LMAT) from Buy to Hold and raises the price target fr...